fda bpc-157 safety risks compounding In 2023, the deemed 19 peptides too unsafe to be dispensed by pharmacies. Now, under RFK Jr., the agency is poised to reverse itself — despite the fact that few FDA issued 25 warning letters
Description
Too much doesn't necessarily work better and increases side effect risk
Interest in this peptide mainly stems from its potential impact on the body's regenerative mechanisms

CONCLUSION The study results indicate that NASO B12 provides absorption of substantially higher amounts of methylcobalamin when compared with that provided by methylcobalamin tablets

Some patients report initial improvements in symptoms within 1-2 weeks, while more significant healing typically develops over 4-8 weeks

[DOI] [PMC free article] [PubMed] [Google Scholar] 66.Collins C.P., Longo D.L., Murphy W.J